ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
2026 Nuclear Energy Conference & Expo (NECX)
August 24–27, 2026
Dallas, TX|Hilton Anatole
Latest Magazine Issues
Jun 2026
Jan 2026
2026
Latest Journal Issues
Nuclear Science and Engineering
July 2026
Nuclear Technology
June 2026
Fusion Science and Technology
May 2026
Latest News
North American construction is back—smaller and faster—at OPG’s Darlington
“The nuclear renaissance is real here,” said Ontario Power Generation’s Subo Sinnathamby on May 8, one year to the day after OPG secured a final investment decision to build the first of four planned BWRX-300 reactors at its Darlington nuclear power plant, and shortly after the new reactor’s foundation was lifted into place. “We got our license to construct in April and our [final investment decision] in May, and we’ve been off to the races since.”
B.F. Peterman, J.R. Johnson, R.G.C. McElroy
Fusion Science and Technology | Volume 8 | Number 2 | September 1985 | Pages 2557-2563
Environmental Study | Proceedings of the Second National Topical Meeting on Tritium Technology in Fission, Fusion and Isotopic Applications (Dayton, Ohio, April 30 to May 2, 1985) | doi.org/10.13182/FST85-A24664
Articles are hosted by Taylor and Francis Online.
This paper describes a study on metabolism of inhaled tritiated hydrogen gas (HT) in mammals. Rats and human volunteers were exposed to HT gas for periods from one minute to ten minutes. The amount of HT that was oxidized in vivo was estimated by measuring the concentration of HTO in urine. No significant quantities of tritiated organic compounds resulting from HT gas inhalation were observed in tissues of rats and it is assumed that this holds true for humans also. The fraction of inhaled HT converted to HTO in human volunteers was found to be about 1 × 10−4 indicating that the dose from the HTO that resulted from HT oxidiation is a significant component of the effective dose equivalent.